Advanced prostate cancer research hub
5 indexed studies · 3 currently recruiting
- authorisedHuman Pharmacology (Phase I)- First administration to humans
JNJ-98768111 for Advanced Prostate Cancer
This early-stage clinical trial tests a new drug called JNJ-98768111 in men with advanced prostate cancer. Because it is a Phase 1 study, it is being tested in humans for the first time. Doctors want to see if the medicine is safe, find the right dose, and monitor side effects.
Spain - recruitingTherapeutic exploratory (Phase II)
A Phase 2, randomized, open-label, dose-finding study of Debio 4228, an extended-release formulation of gonadotropin-releasing hormone antagonist in participants with advanced prostate cancer
This Phase 2 trial tests a slow-release injection called Debio 4228 for men with advanced prostate cancer. The drug works by lowering testosterone, a hormone that fuels prostate cancer growth. Researchers want to find the safest and most effective dose, measure drug levels, and monitor side effects.
France · Belgium · Spain - recruitingPHASE1, PHASE2
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
This study is testing a new drug called GDC-1261 for men with advanced prostate cancer that has spread. We want to see if it's safe, how it works in the body, and if it shows early signs of helping. The aim is to find the best dose for future research.
United States · Australia · United Kingdom - recruitingPHASE1
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
This study is testing a new drug, RO7656594, for men with advanced prostate cancer that has spread. It aims to see if the drug is safe, how it works in the body, and if it shows any early signs of helping people, helping doctors find the best dose.
United States · Australia · Canada - authorisedTherapeutic exploratory (Phase II)
A Phase 2, Open-Label, Single-Arm, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Participants with Advanced Prostate Cancer
This study looks at a new drug, Teverelix, for men with advanced prostate cancer. We want to see how well it lowers testosterone, a hormone that can make prostate cancer grow, and if it's safe to use.
Lithuania